[Glucocorticoids: a two-edged sword in tumor therapy?].
Kelm-Kahl
Inge
I
D000818:Animals; D000932:Antiemetics / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects*; D004359:Drug Therapy, Combination; D005260:Female; D015316:Genetic Therapy; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D017829:Granisetron / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D014407:Tumor Cells, Cultured; D014839:Vomiting / Q000188:drug therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D017829:Granisetron
Glukokortikode--ein zweischneidiges Schwert in der Tumortherapie?